AN2 Therapeutics, Inc. (ANTX) ROE
- 2026-06-30: ROE -47.73%.
- 2026-03-31: ROE -42.22%.
- 2025-12-31: ROE -66.22%.
- 2025-09-30: ROE -56.29%.
Complete source-backed roe history.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-06-30 | -47.73% |
|---|
| 2026-03-31 | -42.22% |
|---|
| 2025-12-31 | -66.22% |
|---|
| 2025-09-30 | -56.29% |
|---|
| 2025-06-30 | -54.30% |
|---|
| 2025-03-31 | -61.85% |
|---|
| 2024-12-31 | -62.70% |
|---|
| 2024-09-30 | -69.27% |
|---|
| 2024-06-30 | -65.77% |
|---|
| 2024-03-31 | -59.73% |
|---|
| 2023-12-31 | -51.94% |
|---|
| 2023-09-30 | -42.94% |
|---|
| 2023-06-30 | -61.88% |
|---|
| 2023-03-31 | -58.93% |
|---|
| 2022-12-31 | -42.94% |
|---|
| 2022-09-30 | -34.72% |
|---|
| 2022-06-30 | -27.85% |
|---|
| 2022-03-31 | -23.52% |
|---|
| 2021-12-31 | 45.44% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-12-31 | -66.29% |
|---|
| 2024-12-31 | -62.70% |
|---|
| 2023-12-31 | -51.91% |
|---|
| 2022-12-31 | -42.94% |
|---|
| 2021-12-31 | 45.44% |
|---|